Save 50% on the Gibco LV-MAX Lentiviral Production System

The first optimized system that provides a scalable and high-yield lentiviral vector production platform.

The LV-MAX Lentiviral Production System provides:

  • High titer – greater than 1 x 108 TU/mL (unconcentrated LVVs-GFP)
  • Scalable suspension system – from 96 deep-well plate to 2-L bioreactor
  • Serum-free – eliminating animal-origin components and associated risks
  • Easy, robust culture and transfection protocols – fits into current transient production workflows
Save 50% ›